Doximity director Cabral proposes $375K share sale
Cabral's reported sales during the preceding three months included 7,500 common shares valued at $293,325.00 on August 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Doximity, Inc. (DOCS) director Timothy Stephen Cabral reported a proposed sale of 10,721 common shares, with an aggregate market value of $375,235.00 and an approximate sale date of November 5, 2026. The associated securities entries list 7,500 shares from a stock option exercise dated November 5, 2026, and 3,221 shares of restricted stock dated August 27, 2026. Cabral also reported selling 7,500 common shares on August 7, 2026, for $293,325.00.
Key Figures
Key Terms
Stock Option Exercise technical
Restricted Stock financial
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.